N-α-Boc-N-δ-xanthyl-D-glutamine is a protected amino acid derivative of glutamine featuring an N-α Boc (tert-butoxycarbonyl) protecting group and an N-δ xanthyl substituent on the side-chain amide nitrogen, with the backbone corresponding to the D-glutamine stereochemical form. The molecule retains the free carboxyl group and the α-amino functionality is masked by Boc, while the side-chain amide is further substituted at the δ-nitrogen, altering hydrogen-bonding and nucleophilicity relative to unprotected glutamine. As a protected, chemoselectively masked building block, it is used in stepwise peptide synthesis and related peptide-derivative preparation where controlled exposure of the α-amino and carboxyl groups supports sequential coupling and minimizes side reactions from the side-chain amide.
N-α-Boc-N-δ-xanthyl-D-glutamine is a D-glutamine-derived, side-chain functionalized amino acid derivative featuring an N-terminal Boc-protecting group and a δ-amide side chain bearing a xanthyl substituent. The molecule contains the stereogenic D-configured α-carbon, a protected backbone nitrogen, and a carboxamide motif whose substitution pattern modulates nucleophilicity and coupling behavior relative to unprotected glutamine. The Boc group provides acid-labile protection for peptide coupling workflows, while the xanthyl group on the δ-nitrogen can serve as a removable or transformable handle for downstream side-chain derivatization. The resulting protected amino acid building block is engineered for controlled reactivity in peptide synthesis, enabling selective deprotection and functional-group manipulation without perturbing the stereochemical integrity of the D-glutamine core.
1. Peptide Synthesis
N-α-Boc-N-δ-xanthyl-D-glutamine supports peptide building block preparation in solid-phase or solution-phase coupling strategies where N-terminal Boc protection is required to suppress unproductive backbone reactions. The Boc-protected α-amino group can be activated for amide bond formation after controlled deprotection, while the δ-side-chain amide substitution influences side-chain participation during coupling and post-coupling steps. The D-glutamine stereocenter allows incorporation of a D-configured glutamine residue into peptides and peptidomimetics, enabling stereochemical control of backbone conformation and side-chain orientation. Side-chain functionalization enabled by the xanthyl-protected δ-nitrogen can be carried through synthesis as a protected handle for later conversion into alternative glutamine-like functionalities.
2. Protected Amino Acids
N-α-Boc-N-δ-xanthyl-D-glutamine functions as a protected amino acid intermediate for derivatization planning that separates backbone protection (Boc) from side-chain nitrogen management (xanthyl substitution). The orthogonal protection pattern can be exploited to design stepwise deprotection sequences in which the α-amino group is unmasked for peptide coupling while the δ-amide nitrogen remains masked or selectively transformed. The presence of both a Boc carbamate and a substituted side-chain amide provides a defined reactivity profile for reagent compatibility in peptide coupling chemistry, including carbodiimide- or uronium-mediated activation regimes. The compound's protected architecture is suitable for manufacturing route development where controlled functional-group exposure reduces side reactions and supports reproducible intermediate formation.
3. Chemical Biology Probes
N-α-Boc-N-δ-xanthyl-D-glutamine can be applied to chemical biology research workflows that require D-glutamine-containing peptide analogs or labeled glutamine mimetics for binding studies and mechanistic assays. The protected δ-amide nitrogen and the xanthyl substituent can be leveraged as a handle for subsequent conversion to reactive or tag-compatible forms, such as conjugation-ready amide derivatives or side-chain-modified analogs used in probe construction. Boc protection enables incorporation into peptide scaffolds with minimal interference from the side-chain functionality during assembly, supporting controlled presentation of the glutamine-like motif. Downstream transformation of the δ-nitrogen substituent can enable generation of analogs for studying recognition pathways, substrate specificity, or protein-ligand interactions where D-amino acid content tunes stability and conformational behavior.
4. Peptidomimetic Construction
N-α-Boc-N-δ-xanthyl-D-glutamine serves as a stereodefined chiral input for peptidomimetic construction where D-glutamine residues are used to modulate proteolytic stability and backbone geometry. The α-carboxamide-derived side chain and protected δ-nitrogen enable controlled elaboration into constrained or functionalized glutamine analogs that can be incorporated into larger scaffolds. Boc protection supports sequential assembly of amide linkages while the xanthyl substitution can be retained during early steps and then converted to alternative side-chain chemistries to generate structure-activity relationship (SAR) libraries. The resulting intermediates are suitable for fine chemical synthesis of peptide analogs intended for SAR studies, fragment-based optimization, and scaffold diversification in applied molecular design programs.
5. Pharmaceutical Manufacturing Intermediates
N-α-Boc-N-δ-xanthyl-D-glutamine can be employed in pharmaceutical manufacturing contexts as a protected amino acid intermediate for controlled synthesis of D-glutamine-containing peptide intermediates. The orthogonal protection scheme, combining an acid-labile Boc group with a side-chain δ-nitrogen substituent, supports manufacturing process design that separates coupling steps from later functional-group adjustments. The stereochemical integrity of the D-configured α-carbon reduces the risk of racemization during protected intermediate handling, aligning with process chemistry requirements for stereodefined inputs. The compound can feed downstream formation of peptide-active intermediates and related peptidomimetic building blocks used in specialty chemical production where reproducible functional-group patterns are required for consistent downstream conversion.
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More